O	O	O	0	14	Identification	Identification	B-NP	NN	O	0	ROOT	O
O	O	O	15	17	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	18	19	a	a	B-NP	DT	O	8	NMOD	O
T13	B-Entity	B-Entity	20	25	human	human	I-NP	JJ	B-DNA	8	NMOD	B-DNA
T13	I-Entity	I-Entity	26	29	LIM	LIM	I-NP	NN	I-DNA	8	NMOD	I-DNA
T13	I-Entity	I-Entity	29	30	-	-	I-NP	HYPH	I-DNA	8	NMOD	I-DNA
T13	I-Entity	I-Entity	30	33	Hox	Hox	I-NP	NN	I-DNA	8	NMOD	I-DNA
T13	I-Entity	I-Entity	34	38	gene	gene	I-NP	NN	I-DNA	2	PMOD	I-DNA
O	O	O	38	39	,	,	O	,	O	10	P	O
T1	B-Protein	B-Protein	40	43	hLH	hLH	B-NP	NN	B-DNA	8	NMOD	B-DNA
T1	I-Protein	I-Protein	43	44	-	-	O	HYPH	I-DNA	10	P	I-DNA
T1	I-Protein	I-Protein	44	45	2	2	B-NP	CD	I-DNA	10	NMOD	I-DNA
O	O	O	45	46	,	,	O	,	O	10	P	O
O	O	O	47	57	aberrantly	aberrantly	B-VP	RB	O	15	VMOD	O
O	O	O	58	67	expressed	express	I-VP	VBN	O	10	NMOD	O
O	O	O	68	70	in	in	B-PP	IN	O	15	VMOD	O
O	O	O	71	78	chronic	chronic	B-NP	JJ	O	19	NMOD	O
O	O	O	79	90	myelogenous	myelogenous	I-NP	JJ	O	19	NMOD	O
O	O	O	91	100	leukaemia	leukaemia	I-NP	NN	O	16	PMOD	O
O	O	O	101	104	and	and	O	CC	O	15	DEP	O
O	O	O	105	112	located	locate	B-VP	VBN	O	15	VMOD	O
O	O	O	113	115	on	on	B-PP	IN	O	21	AMOD	O
T14	B-Entity	B-Entity	116	120	9q33	9q33	B-NP	CD	B-DNA	25	NMOD	B-DNA
T14	I-Entity	I-Entity	120	121	-	-	I-NP	HYPH	O	25	P	O
T14	I-Entity	I-Entity	121	123	34	34	I-NP	CD	O	22	PMOD	O
T14	I-Entity	I-Entity	123	124	.	.	I-NP	.	O	25	P	O
T14	I-Entity	I-Entity	124	125	1	1	I-NP	CD	O	25	NMOD	O
O	O	O	125	126	.	.	O	.	O	1	P	O

O	O	O	128	130	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	131	139	describe	describe	B-VP	VBP	O	0	ROOT	O
O	O	O	140	143	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	144	153	isolation	isolation	I-NP	NN	O	2	OBJ	O
O	O	O	154	156	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	157	162	human	human	B-NP	JJ	B-protein	8	NMOD	B-protein
T2	B-Protein	B-Protein	163	165	LH	LH	I-NP	NN	I-protein	8	NMOD	I-protein
T2	I-Protein	I-Protein	165	166	-	-	O	HYPH	I-protein	14	NMOD	I-protein
T2	I-Protein	I-Protein	166	167	2	2	B-NP	CD	I-protein	8	NMOD	I-protein
O	O	O	167	168	,	,	O	,	O	14	P	O
O	O	O	169	170	a	a	B-NP	DT	O	14	NMOD	O
O	O	O	171	179	putative	putative	I-NP	JJ	B-protein	14	NMOD	B-protein
O	O	O	180	193	transcription	transcription	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	O	194	200	factor	factor	I-NP	NN	I-protein	5	PMOD	I-protein
O	O	O	201	211	containing	contain	B-VP	VBG	O	14	NMOD	O
O	O	O	212	215	two	two	B-NP	CD	O	34	NMOD	O
T15,T16	B-Entity,B-Entity	B-Entity,B-Entity	216	224	cysteine	cysteine	I-NP	NN	B-protein	20	NMOD	B-protein
T15	I-Entity	I-Entity	224	225	-	-	B-NP	HYPH	I-protein	20	NMOD	I-protein
T15	I-Entity	I-Entity	225	229	rich	rich	I-NP	JJ	I-protein	20	NMOD	I-protein
T15	I-Entity	I-Entity	230	237	regions	region	I-NP	NNS	I-protein	16	NMOD	I-protein
O	O	O	238	239	(	(	O	(	O	24	DEP	O
T17	B-Entity	B-Entity	239	242	LIM	LIM	B-NP	NN	B-protein	23	NMOD	B-protein
T17	I-Entity	I-Entity	243	250	domains	domain	I-NP	NNS	I-protein	24	DEP	I-protein
O	O	O	250	251	)	)	O	)	O	20	NMOD	O
O	O	O	252	255	and	and	O	CC	O	34	NMOD	O
O	O	O	256	257	a	a	B-NP	DT	O	34	NMOD	O
T18	B-Entity	B-Entity	258	266	homeobox	homeobox	I-NP	NN	B-protein	34	NMOD	B-protein
T18	I-Entity	I-Entity	267	268	(	(	O	(	I-protein	34	NMOD	I-protein
T18	I-Entity	I-Entity	268	271	Hox	Hox	B-NP	NN	I-protein	34	NMOD	I-protein
T18	I-Entity	I-Entity	271	272	)	)	O	)	I-protein	34	NMOD	I-protein
T18	I-Entity	I-Entity	273	276	DNA	DNA	B-NP	NN	I-protein	34	NMOD	I-protein
T18	I-Entity	I-Entity	276	277	-	-	B-PP	HYPH	I-protein	34	NMOD	I-protein
T18	I-Entity	I-Entity	277	284	binding	bind	B-NP	VBG	I-protein	34	NMOD	I-protein
T18	I-Entity	I-Entity	285	291	domain	domain	I-NP	NN	I-protein	15	OBJ	I-protein
O	O	O	291	292	.	.	O	.	O	2	P	O

O	O	O	293	297	High	High	B-NP	JJ	O	2	NMOD	O
O	O	O	298	304	levels	level	I-NP	NNS	O	8	SUB	O
O	O	O	305	307	of	of	B-PP	IN	O	2	NMOD	O
T3	B-Protein	B-Protein	308	311	hLH	hLH	B-NP	NN	B-DNA	7	NMOD	B-DNA
T3	I-Protein	I-Protein	311	312	-	-	O	HYPH	I-DNA	7	NMOD	I-DNA
T3	I-Protein	I-Protein	312	313	2	2	B-NP	CD	I-DNA	7	NMOD	I-DNA
O	O	O	314	324	expression	expression	I-NP	NN	O	3	PMOD	O
O	O	O	325	329	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	330	338	observed	observe	I-VP	VBN	O	8	VC	O
O	O	O	339	341	in	in	B-PP	IN	O	9	VMOD	O
O	O	O	342	345	all	all	B-NP	DT	O	12	NMOD	O
O	O	O	346	351	cases	case	I-NP	NNS	O	10	PMOD	O
O	O	O	352	354	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	355	362	chronic	chronic	B-NP	JJ	O	16	NMOD	O
O	O	O	363	374	myelogenous	myelogenous	I-NP	JJ	O	16	NMOD	O
O	O	O	375	384	leukaemia	leukaemia	I-NP	NN	O	13	PMOD	O
O	O	O	385	386	(	(	O	(	O	19	DEP	O
O	O	O	386	389	CML	CML	B-NP	NN	O	19	DEP	O
O	O	O	389	390	)	)	O	)	O	16	NMOD	O
O	O	O	391	397	tested	test	B-VP	VBN	O	16	NMOD	O
O	O	O	397	398	,	,	O	,	O	20	P	O
O	O	O	399	409	regardless	regardless	B-ADVP	RB	O	20	VMOD	O
O	O	O	410	412	of	of	B-PP	IN	O	22	AMOD	O
O	O	O	413	420	disease	disease	B-NP	NN	O	25	NMOD	O
O	O	O	421	427	status	status	I-NP	NN	O	23	PMOD	O
O	O	O	427	428	.	.	O	.	O	8	P	O

T4	B-Protein	B-Protein	429	432	hLH	hLH	B-NP	NN	B-DNA	4	SUB	B-DNA
T4	I-Protein	I-Protein	432	433	-	-	O	HYPH	I-DNA	1	P	I-DNA
T4	I-Protein	I-Protein	433	434	2	2	B-NP	CD	I-DNA	1	NMOD	I-DNA
O	O	O	435	438	was	be	B-VP	VBD	O	46	VMOD	O
O	O	O	439	445	mapped	map	I-VP	VBN	O	4	VC	O
O	O	O	446	448	to	to	B-PP	TO	O	5	VMOD	O
T19	B-Entity	B-Entity	449	459	chromosome	chromosome	B-NP	NN	B-DNA	9	NMOD	B-DNA
T19	I-Entity	I-Entity	460	464	9Q33	9Q33	I-NP	CD	I-DNA	7	NMOD	I-DNA
T19	I-Entity	I-Entity	464	465	-	-	I-NP	HYPH	O	6	PMOD	O
T19	I-Entity	I-Entity	465	467	34	34	I-NP	CD	O	9	NMOD	O
T19	I-Entity	I-Entity	467	468	.	.	I-NP	.	O	9	P	O
T19	I-Entity	I-Entity	468	469	1	1	I-NP	CD	O	9	NMOD	O
O	O	O	469	470	,	,	O	,	O	9	P	O
O	O	O	471	473	in	in	B-PP	IN	O	5	VMOD	O
O	O	O	474	477	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	478	482	same	same	I-NP	JJ	O	17	NMOD	O
O	O	O	483	489	region	region	I-NP	NN	O	14	PMOD	O
O	O	O	490	492	as	as	B-PP	IN	O	5	VMOD	O
O	O	O	493	496	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	497	507	reciprocal	reciprocal	I-NP	JJ	O	21	NMOD	O
O	O	O	508	521	translocation	translocation	I-NP	NN	O	18	PMOD	O
O	O	O	522	526	that	that	B-NP	WDT	O	21	NMOD	O
O	O	O	527	534	creates	create	B-VP	VBZ	O	22	SBAR	O
O	O	O	535	538	the	the	B-NP	DT	O	28	NMOD	O
T5	B-Protein	B-Protein	539	542	BCR	BCR	I-NP	NN	B-protein	28	NMOD	B-protein
O	O	O	542	543	-	-	B-NP	HYPH	O	28	NMOD	O
T6	B-Protein	B-Protein	543	546	ABL	ABL	I-NP	NN	O	28	NMOD	O
O	O	O	547	554	chimera	chimera	I-NP	NN	O	39	NMOD	O
O	O	O	555	557	of	of	B-PP	IN	O	28	NMOD	O
O	O	O	558	561	the	the	B-NP	DT	O	32	NMOD	O
O	O	O	562	574	Philadelphia	Philadelphia	I-NP	NNP	O	32	NMOD	O
O	O	O	575	585	chromosome	chromosome	I-NP	NN	O	29	PMOD	O
O	O	O	586	587	(	(	O	(	O	36	DEP	O
O	O	O	587	589	Ph	Ph	B-NP	NN	O	36	DEP	O
O	O	O	589	590	'	'	O	''	O	34	NMOD	O
O	O	O	590	591	)	)	O	)	O	32	NMOD	O
O	O	O	591	592	,	,	O	,	O	39	P	O
O	O	O	593	596	the	the	B-NP	DT	O	39	NMOD	O
O	O	O	597	605	hallmark	hallmark	I-NP	NN	O	23	OBJ	O
O	O	O	606	608	of	of	B-PP	IN	O	39	NMOD	O
O	O	O	609	612	CML	CML	B-NP	NN	O	40	PMOD	O
O	O	O	612	613	;	;	O	:	O	4	P	O
T7	B-Protein	B-Protein	614	617	hLH	hLH	B-NP	NN	B-DNA	46	SUB	B-DNA
T7	I-Protein	I-Protein	617	618	-	-	O	HYPH	I-DNA	43	NMOD	I-DNA
T7	I-Protein	I-Protein	618	619	2	2	B-NP	CD	I-DNA	43	NMOD	I-DNA
O	O	O	620	623	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	624	632	retained	retain	I-VP	VBN	O	46	VC	O
O	O	O	633	635	on	on	B-PP	IN	O	47	VMOD	O
O	O	O	636	639	the	the	B-NP	DT	O	52	NMOD	O
O	O	O	640	650	derivative	derivative	I-NP	JJ	B-DNA	52	NMOD	B-DNA
O	O	O	651	652	9	9	I-NP	CD	I-DNA	52	NMOD	I-DNA
O	O	O	653	663	chromosome	chromosome	I-NP	NN	I-DNA	48	PMOD	I-DNA
O	O	O	664	667	and	and	O	CC	O	46	VMOD	O
O	O	O	668	670	is	be	B-VP	VBZ	O	46	VMOD	O
O	O	O	671	680	therefore	therefore	B-ADVP	RB	O	54	VMOD	O
O	O	O	681	692	centromeric	centromeric	B-ADJP	JJ	O	54	PRD	O
O	O	O	693	695	of	of	B-PP	IN	O	56	AMOD	O
T8	B-Protein	B-Protein	696	697	c	c	B-NP	NN	O	60	NMOD	O
T8	I-Protein	I-Protein	697	698	-	-	I-NP	HYPH	O	60	NMOD	O
T8	I-Protein	I-Protein	698	701	ABL	ABL	I-NP	NN	B-protein	57	PMOD	B-protein
O	O	O	701	702	.	.	O	.	O	46	P	O

O	O	O	703	706	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	707	716	proximity	proximity	I-NP	NN	O	13	SUB	O
O	O	O	717	719	of	of	B-PP	IN	O	2	NMOD	O
T9	B-Protein	B-Protein	720	723	hLH	hLH	B-NP	NN	B-DNA	3	PMOD	B-DNA
T9	I-Protein	I-Protein	723	724	-	-	O	HYPH	I-DNA	6	P	I-DNA
T9	I-Protein	I-Protein	724	725	2	2	B-NP	CD	I-DNA	4	NMOD	I-DNA
O	O	O	726	728	to	to	B-PP	TO	O	6	NMOD	O
O	O	O	729	732	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	733	743	breakpoint	breakpoint	I-NP	NN	O	7	PMOD	O
O	O	O	744	746	on	on	B-PP	IN	O	9	NMOD	O
O	O	O	747	757	chromosome	chromosome	B-NP	NN	B-DNA	10	PMOD	B-DNA
O	O	O	758	759	9	9	I-NP	CD	I-DNA	11	NMOD	I-DNA
O	O	O	760	766	raises	raise	B-VP	VBZ	O	0	ROOT	O
O	O	O	767	770	the	the	B-NP	DT	O	15	NMOD	O
O	O	O	771	782	possibility	possibility	I-NP	NN	O	13	OBJ	O
O	O	O	783	785	of	of	B-PP	IN	O	15	NMOD	O
O	O	O	786	789	cis	cis	B-NP	NN	B-protein	19	NMOD	B-protein
O	O	O	789	790	-	-	O	HYPH	O	19	P	O
O	O	O	790	800	activation	activation	B-NP	NN	O	16	PMOD	O
O	O	O	801	803	by	by	B-PP	IN	O	19	NMOD	O
O	O	O	804	807	the	the	B-NP	DT	O	26	NMOD	O
T20	B-Entity	B-Entity	808	809	t	t	I-NP	NN	B-DNA	26	NMOD	B-DNA
T20	I-Entity	I-Entity	809	810	(	(	O	(	I-DNA	22	NMOD	I-DNA
T20	I-Entity	I-Entity	810	811	9	9	B-NP	CD	I-DNA	26	NMOD	I-DNA
T20	I-Entity	I-Entity	811	812	;	;	O	:	I-DNA	26	P	I-DNA
T20	I-Entity	I-Entity	812	814	22	22	B-NP	CD	I-DNA	33	NMOD	I-DNA
T20	I-Entity	I-Entity	814	815	)	)	O	)	I-DNA	26	NMOD	I-DNA
T20	I-Entity	I-Entity	815	816	(	(	O	(	I-DNA	32	DEP	I-DNA
T20	I-Entity	I-Entity	816	819	q34	q34	B-NP	NN	I-DNA	31	NMOD	I-DNA
T20	I-Entity	I-Entity	819	820	;	;	O	:	I-DNA	31	P	I-DNA
T20	I-Entity	I-Entity	820	823	q11	q11	B-NP	NN	I-DNA	32	DEP	I-DNA
T20	I-Entity	I-Entity	823	824	)	)	O	)	I-DNA	26	NMOD	I-DNA
O	O	O	825	838	translocation	translocation	B-NP	NN	I-DNA	20	PMOD	I-DNA
O	O	O	838	839	.	.	O	.	O	13	P	O

O	O	O	840	842	In	In	B-PP	IN	O	16	VMOD	O
O	O	O	843	851	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	O	852	854	to	to	B-PP	TO	O	2	NMOD	O
O	O	O	855	862	finding	find	B-VP	VBG	O	3	PMOD	O
T10	B-Protein	B-Protein	863	866	hLH	hLH	B-NP	NN	B-DNA	8	NMOD	B-DNA
T10	I-Protein	I-Protein	866	867	-	-	O	HYPH	I-DNA	8	NMOD	I-DNA
T10	I-Protein	I-Protein	867	868	2	2	B-NP	CD	I-DNA	8	NMOD	I-DNA
O	O	O	869	879	expression	expression	I-NP	NN	O	4	OBJ	O
O	O	O	880	882	in	in	B-PP	IN	O	4	VMOD	O
O	O	O	883	886	all	all	B-NP	DT	O	11	NMOD	O
O	O	O	887	892	cases	case	I-NP	NNS	O	9	PMOD	O
O	O	O	893	895	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	896	899	CML	CML	B-NP	NN	O	12	PMOD	O
O	O	O	899	900	,	,	O	,	O	16	P	O
O	O	O	901	911	expression	expression	B-NP	NN	O	16	SUB	O
O	O	O	912	915	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	916	924	observed	observe	I-VP	VBN	O	16	VC	O
O	O	O	925	927	in	in	B-PP	IN	O	17	VMOD	O
O	O	O	928	936	lymphoid	lymphoid	B-NP	JJ	O	20	NMOD	O
O	O	O	937	949	malignancies	malignancy	I-NP	NNS	O	24	NMOD	O
O	O	O	950	953	and	and	O	CC	O	24	NMOD	O
O	O	O	954	961	myeloid	myeloid	B-NP	JJ	B-cell_line	24	NMOD	B-cell_line
O	O	O	962	966	cell	cell	I-NP	NN	I-cell_line	24	NMOD	I-cell_line
O	O	O	967	972	lines	line	I-NP	NNS	I-cell_line	18	PMOD	I-cell_line
O	O	O	972	973	,	,	B-PP	,	O	18	P	O
O	O	O	974	977	but	but	I-PP	CC	O	18	PMOD	O
O	O	O	978	981	not	not	B-PP	RB	O	28	PMOD	O
O	O	O	982	984	in	in	I-PP	IN	O	18	PMOD	O
O	O	O	985	992	primary	primary	B-NP	JJ	O	30	NMOD	O
O	O	O	993	998	cases	case	I-NP	NNS	O	28	PMOD	O
O	O	O	999	1001	of	of	B-PP	IN	O	30	NMOD	O
O	O	O	1002	1007	acute	acute	B-NP	JJ	O	34	NMOD	O
O	O	O	1008	1019	myelogenous	myelogenous	I-NP	JJ	O	34	NMOD	O
O	O	O	1020	1029	leukaemia	leukaemia	I-NP	NN	O	31	PMOD	O
O	O	O	1029	1030	.	.	O	.	O	16	P	O

O	O	O	1031	1034	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	1035	1039	role	role	I-NP	NN	O	14	SUB	O
O	O	O	1040	1042	of	of	B-PP	IN	O	2	NMOD	O
T11	B-Protein	B-Protein	1043	1046	hLH	hLH	B-NP	NN	B-DNA	5	NMOD	B-DNA
T11	I-Protein	I-Protein	1046	1047	-	-	B-NP	HYPH	I-DNA	3	PMOD	I-DNA
T11	I-Protein	I-Protein	1047	1048	2	2	I-NP	CD	I-DNA	5	NMOD	I-DNA
O	O	O	1049	1051	in	in	B-PP	IN	O	2	NMOD	O
O	O	O	1052	1055	the	the	B-NP	DT	O	11	NMOD	O
O	O	O	1056	1067	development	development	I-NP	NN	O	11	NMOD	O
O	O	O	1068	1070	or	or	I-NP	CC	O	11	NMOD	O
O	O	O	1071	1082	progression	progression	I-NP	NN	O	7	PMOD	O
O	O	O	1083	1085	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	1086	1095	leukaemia	leukaemia	B-NP	NN	O	12	PMOD	O
O	O	O	1096	1098	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1099	1102	not	not	I-VP	RB	O	14	VMOD	O
O	O	O	1103	1108	known	know	I-VP	VBN	O	14	VC	O
O	O	O	1108	1109	.	.	O	.	O	14	P	O

O	O	O	1110	1117	However	However	B-ADVP	RB	O	6	VMOD	O
O	O	O	1117	1118	,	,	O	,	O	6	P	O
T12	B-Protein	B-Protein	1119	1122	hLH	hLH	B-NP	NN	B-DNA	4	NMOD	B-DNA
T12	I-Protein	I-Protein	1122	1123	-	-	O	HYPH	I-DNA	6	P	I-DNA
T12	I-Protein	I-Protein	1123	1124	2	2	B-NP	CD	I-DNA	4	NMOD	I-DNA
O	O	O	1125	1128	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	1129	1134	prove	prove	I-VP	VB	O	6	VC	O
O	O	O	1135	1141	useful	useful	B-ADJP	JJ	O	7	PRD	O
O	O	O	1142	1144	as	as	B-PP	IN	O	8	AMOD	O
O	O	O	1145	1146	a	a	B-NP	DT	O	11	NMOD	O
O	O	O	1147	1153	marker	marker	I-NP	NN	O	9	PMOD	O
O	O	O	1154	1156	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	1157	1160	CML	CML	B-NP	NN	O	12	PMOD	O
O	O	O	1161	1164	for	for	B-PP	IN	O	11	NMOD	O
O	O	O	1165	1175	monitoring	monitor	B-VP	VBG	O	14	PMOD	O
O	O	O	1176	1184	residual	residual	B-NP	JJ	O	17	NMOD	O
O	O	O	1185	1192	disease	disease	I-NP	NN	O	15	OBJ	O
O	O	O	1192	1193	.	.	O	.	O	6	P	O
